Chen Hongwei, Deputy Director of the Provincial Drug Administration, Leads a Team to the Company for Research
On July 21, Chen Hongwei, Deputy Director of the Provincial Drug Administration; Peng Xufeng, Chief Engineer; Li Ya, Director of the Law Enforcement and Supervision Division; and Feng Yuxue, First-Class Researcher of the Law Enforcement and Supervision Division, came to the company for research, carefully learning about the company's business operations and quality management. They discussed and studied solutions together for the problems facing the enterprise, and listened to opinions and suggestions on issues such as license approval, information disclosure, and support for enterprise innovation and development.
As the directly responsible leader of the "10,000 Enterprises Assistance" campaign for our company, Deputy Director Chen Hongwei toured the pharmaceutical production workshop, the quality inspection center and the R&D center, learned about the company's development history, and listened to the company's work report, affirming the company's achievements in business operations, pharmaceutical R&D and quality management. He also pointed out that the "10,000 Enterprises Assistance" campaign is an important decision and deployment made by the Provincial Party Committee and the Provincial Government based on the province's actual conditions and aimed at high-quality development in the new era. The Provincial Drug Administration has always adhered to the concept that "serving enterprises means serving the overall work of the province." As the drug regulatory authority, it should go deeper into enterprises more often, enhance service awareness, innovate working methods and approaches, and deliver tangible results. "We will fully study the opinions and suggestions put forward by enterprises, propose innovative measures, help enterprises solve practical problems, and fully stimulate the development potential of enterprises," he said.
At the conclusion of the research visit, Deputy Director Chen Hongwei fully affirmed the company's business operations, remarking that both the company's management and the spirit of its personnel are full of vitality and vigor. He stressed that quality is the lifeline of pharmaceutical manufacturers. Pharmaceutical enterprises must uphold the concept of safe development, strictly implement their primary responsibility for drug safety, continuously improve the quality management system for pharmaceutical production, and operate in compliance with the law and with integrity. They should seize opportunities, intensify innovation, actively expand markets, and achieve high-quality development.
Yang Yuefeng, Deputy Director of the Xuchang Municipal Administration for Market Regulation; Lu Yi, Director of the Seventh Branch of the Provincial Drug Administration; and Zhang Mingxian, Deputy Director, among other leaders, accompanied the research visit.。
